Evidence map›Paper›PMID 40026630›Full record

ArticleMaterials today. Bio2025

A tumor-targeting black phosphorus-based nanoplatform for controlled chemo-photothermal therapy of breast cancer.

Lin Yang, Ying Zhang, Jing Liu, Xiaofen Wang, Li Zhang, Hao Wan

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lin YangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, PR China.
Ying ZhangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, PR China.
Jing LiuCollege of Pharmacy, Dalian Medical University, Dalian, 116044, PR China.
Xiaofen WangCancer Research Center, Jiangxi University of Chinese Medicine, Nanchang, 330004, PR China.
Li ZhangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, PR China.
Hao WanState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combination therapy with high efficacy and precision shows great potential in breast cancer treatment. Herein, we developed a multifunctional nanocarrier (NBP@mSiO

Indexed as

Chemo-photothermal therapyControlled releaseIndole-3-carbinolNano-sized black phosphorusTumor targeting

Identifiers

PMID40026630
PMCPMC11870200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.